信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·创新药概念强势拉升海创药业一度涨停首药控股再创新高2023-2-2 12:01:07
·科伦药业拟分拆亏损25亿子公司上市刘革新创新转型十年“增收不增利”2023-2-2 11:59:21
·鲁班药业2022年预计净利1500万-2100万同比增长90%-165%产品销售订单增长2023-2-2 11:41:06
·一品制药明星单品营收占46%结构单一三年半市场推广费4.16亿研发费逐年下降2023-2-1 9:53:53
·中泰证券2月策略及金股：关注“安全”主线演绎，推荐航发科技、深信服、明源云、药明生物、五粮液等2023-2-1 9:25:40
·恩威医药（301331）1月31日主力资金净卖出740.08万元2023-2-1 9:21:35
·券商2月金股出炉：这些股获力挺看好消费、医药等板块2023-2-1 9:05:08
·新光药业2022年预计净利1.03亿-1.14亿同比下降0%-10%利息收入与投资收益下降2023-2-1 2:10:03
·华海药业：受托生产和供应新冠药VV116原料药和VV116制剂2023-1-31 21:06:02
·延安医药董事会秘书张伟辞职2022上半年公司净利2681.32万2023-1-31 20:39:21
·股票行情快报：华海药业（600521）1月31日主力资金净卖出1719.88万元2023-1-31 19:41:37
·海创药业：PROTAC药物HP518临床试验申请获FDA批准2023-1-31 16:39:36
·恒瑞医药：注射用SHR-A1811药物临床试验获批2023-1-31 16:22:35
·*ST吉药（300108）1月31日主力资金净卖出856.43万元2023-1-31 15:48:07
·百洋医药（301015）1月30日主力资金净卖出294.30万元2023-1-31 14:53:16
·新华制药（000756）1月30日主力资金净卖出4770.28万元2023-1-31 12:44:31
·新冠重症治疗药物春节开足马力生产 布洛芬等药物恢复稳定供应2023-1-31 12:07:50
·以岭药业2022年预计净利21.50亿-24.19亿同比增加60.00%-80.00%2023-1-31 10:02:37
·18股预计净利润增长10倍连续5年增长的医药股名单出炉2023-1-31 8:51:15
·贵州百灵2022年预计净利1.7亿-2亿同比增长37%-61%疫情防控相关药品市场需求大量增加2023-1-30 23:54:11

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]